- Home
- BTOG vs NAII Comparison
BTOG vs NAII Comparison
Compare BTOG & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTOG | NAII |
|---|---|---|
| Founded | 2018 | 1980 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2M | 21.2M |
| IPO Year | 2019 | 1987 |
Fundamental Metrics
Financial Performance| Metric | BTOG | NAII |
|---|---|---|
| Price | $0.19 | $3.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 17.3K |
| Earning Date | 03-30-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $39,495.00 | ★ $134,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $0.12 | $2.57 |
| 52 Week High | $1.07 | $4.40 |
Technical Indicators
Market Signals| Indicator | BTOG | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 74.39 |
| Support Level | $0.18 | $3.14 |
| Resistance Level | $0.21 | $3.55 |
| Average True Range (ATR) | 0.02 | 0.14 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 46.42 | 100.00 |
Price Performance
Historical ComparisonAbout BTOG Bit Origin Limited
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions. It derives all of its revenue from Bitcoin mining.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.